162 related articles for article (PubMed ID: 8690906)
21. Role of the polymorphic residues in HLA-DR molecules in allele-specific binding of peptide ligands.
Marshall KW; Liu AF; Canales J; Perahia B; Jorgensen B; Gantzos RD; Aguilar B; Devaux B; Rothbard JB
J Immunol; 1994 May; 152(10):4946-57. PubMed ID: 8176213
[TBL] [Abstract][Full Text] [Related]
22. Definition of specific peptide motifs for four major HLA-A alleles.
Kubo RT; Sette A; Grey HM; Appella E; Sakaguchi K; Zhu NZ; Arnott D; Sherman N; Shabanowitz J; Michel H
J Immunol; 1994 Apr; 152(8):3913-24. PubMed ID: 8144960
[TBL] [Abstract][Full Text] [Related]
23. HLA-DQ allelic polymorphisms constrain patterns of class II heterodimer formation.
Kwok WW; Kovats S; Thurtle P; Nepom GT
J Immunol; 1993 Mar; 150(6):2263-72. PubMed ID: 8450211
[TBL] [Abstract][Full Text] [Related]
24. Identification of peptides from autoantigens GAD65 and IA-2 that bind to HLA class II molecules predisposing to or protecting from type 1 diabetes.
Harfouch-Hammoud E; Walk T; Otto H; Jung G; Bach JF; van Endert PM; Caillat-Zucman S
Diabetes; 1999 Oct; 48(10):1937-47. PubMed ID: 10512357
[TBL] [Abstract][Full Text] [Related]
25. Prominent roles of secondary anchor residues in peptide binding to HLA-A24 human class I molecules.
Kondo A; Sidney J; Southwood S; del Guercio MF; Appella E; Sakamoto H; Celis E; Grey HM; Chesnut RW; Kubo RT; Sette A
J Immunol; 1995 Nov; 155(9):4307-12. PubMed ID: 7594589
[TBL] [Abstract][Full Text] [Related]
26. Differences in self-peptide binding between T1D-related susceptible and protective DR4 subtypes.
Ge X; James EA; Reijonen H; Kwok WW
J Autoimmun; 2011 Mar; 36(2):155-60. PubMed ID: 21257290
[TBL] [Abstract][Full Text] [Related]
27. Identification of an HLA-DQ2 peptide binding motif and HLA-DPw3-bound self-peptide by pool sequencing.
Verreck FA; van de Poel A; Termijtelen A; Amons R; Drijfhout JW; Koning F
Eur J Immunol; 1994 Feb; 24(2):375-9. PubMed ID: 8299686
[TBL] [Abstract][Full Text] [Related]
28. Analysis of eluted peptides from type 1 diabetes-susceptible HLA class II molecules identified novel islet protein, heparin/heparan sulfate-interacting protein.
Nakanishi K; Komatsu Y; Kogawa N; Matsushita H
Biochem Biophys Res Commun; 2005 Apr; 329(1):356-61. PubMed ID: 15721314
[TBL] [Abstract][Full Text] [Related]
29. [Relationship between autoantibodies and HLA-DQ genotypes in patients with type 1 diabetes mellitus].
Wang JP; Zhang C; Lin J; Yuan Y; Zhou HF; Huang G; Zhou M; Zhou ZG
Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(34):2380-4. PubMed ID: 18036312
[TBL] [Abstract][Full Text] [Related]
30. HLA-DQB1 alleles may influence the surface expression of DQ molecules in lymphomononuclear cells of type 1 diabetes mellitus patients.
Fernandes AP; Foss MC; Donadi EA
Scand J Immunol; 2004 Mar; 59(3):305-9. PubMed ID: 15030582
[TBL] [Abstract][Full Text] [Related]
31. Different modes of peptide interaction enable HLA-DQ and HLA-DR molecules to bind diverse peptide repertoires.
Raddrizzani L; Sturniolo T; Guenot J; Bono E; Gallazzi F; Nagy ZA; Sinigaglia F; Hammer J
J Immunol; 1997 Jul; 159(2):703-11. PubMed ID: 9218585
[TBL] [Abstract][Full Text] [Related]
32. Limited loss of tolerance to islet autoantigens in ICA+ first degree relatives of patients with type I diabetes expressing the HLA dqb1*0602 allele.
Gianani R; Verge CF; Moromisato-Gianani RI; Yu L; Zhang YJ; Pugliese A; Eisenbarth GS
J Autoimmun; 1996 Jun; 9(3):423-5. PubMed ID: 8816981
[TBL] [Abstract][Full Text] [Related]
33. Modelling of HLA-DQ2 and its interaction with gluten peptides to explain molecular recognition in celiac disease.
Costantini S; Rossi M; Colonna G; Facchiano AM
J Mol Graph Model; 2005 Apr; 23(5):419-31. PubMed ID: 15781184
[TBL] [Abstract][Full Text] [Related]
34. Several common HLA-DR types share largely overlapping peptide binding repertoires.
Southwood S; Sidney J; Kondo A; del Guercio MF; Appella E; Hoffman S; Kubo RT; Chesnut RW; Grey HM; Sette A
J Immunol; 1998 Apr; 160(7):3363-73. PubMed ID: 9531296
[TBL] [Abstract][Full Text] [Related]
35. Molecular properties of HLA-DQ alleles conferring susceptibility to or protection from insulin-dependent diabetes mellitus: keys to the fate of islet beta-cells.
Moustakas AK; Papadopoulos GK
Am J Med Genet; 2002 May; 115(1):37-47. PubMed ID: 12116175
[TBL] [Abstract][Full Text] [Related]
36. The HLA molecules DQA1*0501/B1*0201 and DQA1*0301/B1*0302 share an extensive overlap in peptide binding specificity.
Sidney J; del Guercio MF; Southwood S; Sette A
J Immunol; 2002 Nov; 169(9):5098-108. PubMed ID: 12391226
[TBL] [Abstract][Full Text] [Related]
37. Modulatory role of DR4- to DQ8-restricted CD4 T-cell responses and type 1 diabetes susceptibility.
Ge X; Piganelli JD; Tse HM; Bertera S; Mathews CE; Trucco M; Wen L; Rudert WA
Diabetes; 2006 Dec; 55(12):3455-62. PubMed ID: 17130492
[TBL] [Abstract][Full Text] [Related]
38. HLA-DQB1 codon 57 is critical for peptide binding and recognition.
Kwok WW; Domeier ME; Johnson ML; Nepom GT; Koelle DM
J Exp Med; 1996 Mar; 183(3):1253-8. PubMed ID: 8642268
[TBL] [Abstract][Full Text] [Related]
39. Unique epitopes of glutamic acid decarboxylase autoantibodies in slowly progressive type 1 diabetes.
Kobayashi T; Tanaka S; Okubo M; Nakanishi K; Murase T; Lernmark A
J Clin Endocrinol Metab; 2003 Oct; 88(10):4768-75. PubMed ID: 14557453
[TBL] [Abstract][Full Text] [Related]
40. Self-peptides bound to the type I diabetes associated class II MHC molecules HLA-DQ1 and HLA-DQ8.
Chicz RM; Lane WS; Robinson RA; Trucco M; Strominger JL; Gorga JC
Int Immunol; 1994 Nov; 6(11):1639-49. PubMed ID: 7865457
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
